Company Profile

Company Description

Cellectar Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted therapies for cancer treatment. The company specializes in phospholipid drug conjugates (PDCs), which are designed to deliver cytotoxic agents directly to cancer cells while minimizing damage to healthy tissues. Their lead candidate is being evaluated for various hematologic and solid tumor malignancies. The firm leverages proprietary technology to enhance the precision and efficacy of oncology treatments, aiming to improve patient outcomes. With a strong emphasis on innovation, it collaborates with research institutions to advance its pipeline. The company operates primarily in the U.S., targeting unmet medical needs in oncology.